Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2022-11-01
2024-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiovascular Risk Factors , Complications and Threputic Management Strategies in Patients With Coronary Heart Disease and COVID 19
NCT05092711
Evaluation of Clinical and Antibody Response to Covid-19 Vaccination Strategy in TBRI, Egypt
NCT05017792
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
NCT05347069
Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.
NCT05718531
Monitoring Response to Antiplatelet Therapy
NCT00327041
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Detection of relation between neopterin and cardiac enzymes as CK and troponine in ACS patients
3. Detect relation between neopterin level and in hospital events
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood sample
Blood samples will obtained for measurement of neopterin level through ELIZA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Acute typical chest pain
2. Positive cardiac enzymes
3. ECG show recent ischemic changes
4. ECHO show SWMA
2. Patients with other diseases which may cause increase of neopterin level as viral infections, intracellular bacteria or parasites infections, certain malignancies, allograft rejection
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mina Khairy Alyshaa Gorgy
Mina Khairy Alyshaa Gorgy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Magdy Ibrahim Aldesowky, Lecturer
Role: PRINCIPAL_INVESTIGATOR
Assiut University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut university
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Yehia Taha keshik, Prof. Doctor
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yehia Taha keshik, Prof . Doctor
Role: primary
Magdy Ibrahim El desoky, Lecturer
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Neopterin
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.